INDO US BIO-TECH LTD.
NSE : NABSE : 541304ISIN
CODE : INE250Z01010Industry : AgricultureHouse
: Private
BSE190.50-18.5 (-8.85 % )
PREV CLOSE (Rs.) 209.00
OPEN PRICE (Rs.) 224.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1000
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE
This Company is not listed in NSE
Company News
| Date | Heading | Details |
|---|---|---|
| 24-Apr-2024 | Indo Us Bio-Tech informs about disclosure | <div style="text-align: justify;">Indo Us Bio-Tech has informed that the Company does not fulfill any of the criteria of ‘Large Corporate', as per the framework provided in the SEBI Circular and hence does not fall in the category of ‘Large Corporate' as defined under SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 19-Apr-2024 | Announcement Under Regulation 30- Clarification Letter For Clerical And Typographical Error In Annual Report For The Year 2022-23 | With reference to captioned subject we would like to draw your attention that in the Annual Report of 2022-23 the figure was wrongly mentioned and hence we have updated the same. Further we would like to inform that it was clerical error which was unintentional and not deliberate. Moreover it do not have any imapct on profitability of the Company. |
| 04-Apr-2024 | Clarification sought from Indo Us Bio-Tech Ltd | The Exchange has sought clarification from Indo Us Bio-Tech Ltd on April 4, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited. |
| 11-Jan-2024 | Indo Us Bio-Tech informs about compliances-certificate | <div style="text-align: justify;">Indo Us Bio-Tech has enclosed a Certificate dated 08th Day of January, 2024 under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 31 December, 2023 received from Bigshare Services, Registrar and Share Transfer Agent of the company.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
| 24-Aug-2023 | Indo US Bio Tech enters into RCO with Chhattisgarh State Seed and Agriculture Development Corporation | <p style="text-align: justify;">Indo US Bio-Tech has entered into a Rate Contract (RCO) with Chhattisgarh State Seed and Agriculture Development Corporation for Supply of Hybrid Vegetable Seeds. The Company has entered into a RCO on August 22, 2023. This RCO signifies a significant collaboration that aligns with its business objectives.</p><p style="text-align: justify;">Indo US Bio-Tech is engaged in multi-disciplinary crop improvement research programmes.</p> |
| 24-Aug-2023 | Indo Us Bio Tech informs about disclosure | <p style="text-align: justify;">Indo Us Bio Tech that has informed that the Company has entered into a Rate Contract (RCO) with Chhattisgarh State Seed and Agriculture Development Corporation with reference to RCO-62/2023-24/5401 dated 22-08-2023 for Supply of Hybrid Vegetable Seeds. This RCO signifies a significant collaboration that aligns with its business objectives. </p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p> |
| 07-Jul-2023 | Indo Us Bio-Tech informs about outcome of board meeting | <div style="text-align: justify;">Indo Us Bio-Tech has informed that the meeting of the board of directors of the company was held on Friday, July 7, 2023 at 04:00 PM and concluded on 04:30 PM at the registered office of the company situated at 309, Shanti Mall, Satadhar Char Rasta, Opp. Navrang Tower, Sola Road, Ahmedabad, Gujarat, 380061. The board considered and approved following; Increase in Authorised Share Capital of the Company from Rs. 11,00,00,000 (Eleven Crores only), divided into 1,10,00,000 Equity Shares of Re. 10 (Rupee Ten Only) each to Rs. 21.00,00,000 (Twenty onc Crores only), divided into 2,10,00,000 Equity Shares of Re. 10 (Rupee Ten Only) each and consequent change in Capital Clause of Memorandum of Association of the Company; The Board recommended the Bonus Issue of Equity Shares in the proportion of 1 (One) Equity Share of Rs, 10 each for every 1 (one) Equity Shares of Re 10 each held by the shareholders of the Company as on the record date; Considered and approved Notice of Postal Ballot subject to the approval of the shareholders of the Company and applicable regulatory authorities; The appointment of CS Amrish Gandhi (Membership No. F8193), Proprietor of M/S Amrish Gandhi & Associates as a matters. Scrutinizer for conducting Postal Ballot and E-Voting Process in fair and transparent manner for the above subject Regulations.) The detailed disclosure as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 Annexure-I.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
